24.09.2014 • News

Frank H. Lutz to be new CFO of Bayer MaterialScience

Frank H. Lutz (45) has been appointed CFO of Bayer MaterialScience effective October 1, 2014. He succeeds Dr. Axel Steiger-Bagel, who takes over on November 1 as Senior Bayer Representative for the Benelux countries, based in Diegem, near Brussels. Lutz - like his predecessor - will be a member of the Board of Management of Bayer MaterialScience and that subgroup's Executive Committee.

He will be responsible for all finance-related matters of MaterialScience, which it is planned to float on the stock market as a separate company in 12 to 18 months' time. His responsibilities on the Executive Committee will also include administration and services along with the Europe, Africa and Middle East regions (EMEA / EEMEA).

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read